2022 Critical Care Pharmacy Preparatory Review and Recertification Course -- Cardiovascular Critical Care II, Infectious Diseases I, Hepatic Failure/GI/Endocrine Emergencies, Practice Administration and Development: Protocol Development and Quality Improvement

Monday, April 25, 2022
Available for 4.00 hours of CPE credit
Activity Number: 0217-0000-22-093-H01-P

The Critical Care Pharmacy Preparatory Review and Recertification Course is ideal for pharmacy professionals who are preparing for the Board of Pharmacy Specialties (BPS) Critical Care Pharmacy Specialty Certification Examination, for Board Certified Critical Care Pharmacists (BCCCPs) seeking recertification through continuing education, and for those seeking a self-paced review and refresher of critical care pharmacy topics.

Developed and presented by nationally recognized pharmacy faculty, the course content provides a comprehensive review of the knowledge domains covered in the critical care pharmacy specialty. Using a case-based approach, the course strongly emphasizes the thought processes needed to solve patient care problems in each therapeutic area.

Learning Objectives

1. Manage cardiac arrest from the initiation of basic life support to the use of post-cardiac arrest care.
2. List the indications and contraindications for medication administration during cardiac arrest.
3. Categorize the patient groups that should receive targeted temperature management.
4. Predict the common complications of targeted temperature management and explain how to ameliorate them.
5. Analyze the therapeutic goals and clinical indications for the medications used in hypertensive emergency.
6. Develop risk factor-based empiric antibiotic regimens for patients with suspected ventilator-associated pneumonia.
7. Identify a definitive management strategy for central line-associated bloodstream infections.
8. Describe definitive and supportive care pharmacotherapeutic interventions for patients with severe influenza.
9. Develop empiric and definitive antimicrobial therapy plans for patients with catheter-related urinary tract infection.
10. Differentiate between location of intra-abdominal infection and respective empiric antimicrobial therapy.
11. Describe the role of antibiotic therapy in patients with acute pancreatitis.
12. Develop a definitive management strategy for critically ill patients with severe Clostridioides difficile infection.
13. Recommend empiric and definitive antibiotic therapy for patients with severe postoperative wound infection.
14. Describe the role of pharmacotherapy in the management of severe cutaneous reactions.
15. Identify a disease-specific and supportive care management plan for critically ill patients with novel severe acute respiratory syndrome coronavirus 2.
16. Define acute liver failure (ALF), and develop a treatment strategy to help manage and reduce the complications associated with ALF.
17. Evaluate the severity of an episode of acute pancreatitis, and construct a plan for pharmacologic, nutritional, and surgical management.
18. Identify risk factors and treatment options for gastrointestinal fistulas, postoperative ileus, and postoperative nausea and vomiting.
19. Design a treatment plan for patients who present with an acute upper gastrointestinal bleed.
20. Differentiate between the main endocrine emergencies in the intensive care unit, and be able to design a therapeutic regimen for a patient presenting with each condition.
21. Determine the steps involved in the development of a guideline and/or policy.
22. Demonstrate how to perform a medication use evaluation (MUE) and list high-risk medications and medication-related processes that are suited for a MUE.
23. Describe different quality improvement tools and identify opportunities to optimize outcomes in a critically ill patient population.
24. Identify processes or quality improvement initiatives that would benefit from a gap analysis.
25. Explain types of pharmacotherapeutic interventions and documentation processes, and justify the value of clinical pharmacy services.

Cardiovascular Critical Care II Speakers Speaker: Scott T. Benken, Pharm.D., MHPE, FCCP, FCCM, BCPS Director of Clinical Research, University of Illinois Health Department of Surgery Clinical Pharmacist, Clinical Associate Professor, University of Illinois Chicago College of Pharmacy Chicago, Illinois View Biography Benken

Infectious Diseases I Speakers Speaker: Eric W. Mueller, Pharm.D., FCCP Assistant Director, Clinical Services and Research, UC Health-University of Cincinnati Medical Center Adjunct Associate Professor of Pharmacy Practice and Administration, University of Cincinnati Cincinnati, Ohio View Biography Mueller

Hepatic Failure/GI/Endocrine Emergencies Speakers Speaker: Stephanie Bass, Pharm.D., FCCP, BCCCP, BCPS Medical ICU Clinical Pharmacist Cleveland Clinic Cleveland, Ohio View Biography Bass

Practice Administration and Development: Protocol Development and Quality Improvement Speakers Speaker: Jaime Robenolt Gray, Pharm.D. System Director Medication Safety and Policy Temple University Health System Philadelphia, Pennsylvania View Biography Gray Speaker: Lisa Hall Zimmerman, Pharm.D., B.S.Pharm, FCCP, BCCCP, BCNSP Clinical Pharmacy Specialist, Department of Pharmaceutical Services Royal Oak, Michigan Adjunct Assistant Professor of Pharmacy Practice, Wayne State University, Eugene Applebaum College of Pharmacy and Health Sciences Detroit, Michigan View Biography Hall Zimmerman